Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
about
Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.Significant racial differences in the key factors associated with early graft loss in kidney transplant recipientsA 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic riskTacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.Use of polyclonal/monoclonal antibody therapies in transplantation.Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients.Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver transplant recipients: a systematic review and meta-analysis.Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction.Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.Renal association clinical practice guideline in post-operative care in the kidney transplant recipientComparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis.Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis.Yes, We Still Need IL-2 Receptor Antagonists.Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.
P2860
Q30987986-E8646CEC-4873-4D65-8D41-3CE623523106Q34017371-914FFEA6-F4FC-4BBB-AAD6-E83788D787FFQ35649082-A43461E8-0FAA-4634-8F58-B45869D101BDQ38704635-E512462B-9B42-412F-94B3-350E413C1454Q38706959-13718307-23A7-4FEE-BF30-2DAE58008D4AQ38769922-E000ECDF-5AB1-48C0-91E1-880F69A8E1C7Q38802439-5E98B3A2-1A9B-4F74-B179-1A2AAC6CF03BQ38998606-A0085BAE-0F53-4E83-9892-9F6A66F84520Q40678105-E3FA26F2-DE26-43B1-9B96-3AB250A9D51AQ40746370-234E7C9F-E8C3-43A3-A93A-9E8723A25100Q41107298-70B8483C-5AEB-42FF-BED8-C23AA6167E33Q42343473-54B914EA-D8F9-4B5A-8BBD-0354745A73DCQ42371647-83AAECE0-4644-41BE-B613-8C6F440C16C7Q49545828-EDB64B86-C5A7-4CA0-AD4B-2AF660B5E254Q51694229-670BF77E-65C5-4A8E-855E-4CCA4E86ED81Q54941607-10BECA0B-15F3-4FBA-AE25-7048D6AC4745
P2860
Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prospective randomized control ...... apy in kidney transplantation.
@en
Prospective randomized control ...... apy in kidney transplantation.
@nl
type
label
Prospective randomized control ...... apy in kidney transplantation.
@en
Prospective randomized control ...... apy in kidney transplantation.
@nl
prefLabel
Prospective randomized control ...... apy in kidney transplantation.
@en
Prospective randomized control ...... apy in kidney transplantation.
@nl
P2093
P1433
P1476
Prospective randomized control ...... apy in kidney transplantation.
@en
P2093
Beje Thomas
David J Taber
Holly B Meadows
John W McGillicuddy
Kenneth D Chavin
Nicole A Pilch
Omar Moussa
Prabhakar K Baliga
Signe Denmark
Titte R Srinivas
P304
P356
10.1097/SLA.0000000000000496
P407
P577
2014-05-01T00:00:00Z